European Union -
English -
EMA (European Medicines Agency)
zinbryta
biogen idec ltd - daclizumab - multiple sclerosis - immunosuppressants - zinbryta is indicated in adult patients for the treatment of relapsing forms of multiple sclerosis (rms).
Canada -
English -
Health Canada
zenapax 5mg/ml liquid
hoffmann-la roche limited - daclizumab - liquid - 5mg - daclizumab 5mg - immunosuppressive agents
Canada -
English -
Health Canada
zinbryta solution
biogen canada inc - daclizumab beta - solution - 150mg - daclizumab beta 150mg - immunomodulatory agents
Canada -
English -
Health Canada
zinbryta solution
biogen canada inc - daclizumab beta - solution - 150mg - daclizumab beta 150mg - immunomodulatory agents
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
zenapax 25mg5ml solution for infusion vials
roche products ltd - daclizumab - solution for infusion - 5mg/1ml
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
zinbryta 150mg1ml solution for injection pre-filled pen
biogen idec ltd - daclizumab - solution for injection - 150mg/1ml